Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7001763
Reference Type
Journal Article
Title
Magnetic Nanoparticles in Cancer Therapy and Diagnosis
Author(s)
Farzin, Ali; Etesami, SA; Quint, J; Memic, A; Tamayol, Ali; ,
Year
2020
Is Peer Reviewed?
1
Journal
Advanced Healthcare Materials
EISSN:
2192-2659
Publisher
WILEY
Location
HOBOKEN
Volume
9
Issue
9
PMID
32196144
DOI
10.1002/adhm.201901058
Web of Science Id
WOS:000520852700001
Abstract
There is urgency for the development of nanomaterials that can meet emerging biomedical needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface-area-to-volume ratios that make them attractive for hyperthermia therapy of cancer and targeted drug delivery. Additionally, they can function as contrast agents for magnetic resonance imaging (MRI) and can improve the sensitivity of biosensors and diagnostic tools. Recent advancements in nanotechnology have resulted in the realization of the next generation of MNPs suitable for these and other biomedical applications. This review discusses methods utilized for the fabrication and engineering of MNPs. Recent progress in the use of MNPs for hyperthermia therapy, controlling drug release, MRI, and biosensing is also critically reviewed. Finally, challenges in the field and potential opportunities for the use of MNPs toward improving their properties are discussed.
Keywords
cancer detection; cancer therapy; drug delivery; hyperthermia; magnetic nanoparticles
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity